Despite the increasing volume of research on IL-33, there remains a critical need to consolidate and critically appraise the existing evidence to bridge knowledge gaps and offer more thorough insight into the mechanisms underlying obesity and T2D. The gene discussed is IL33; the disease is type 2 diabetes mellitus.